Joshua Lengieza

Joshua Lengieza is a Senior Associate Scientist at Abata Therapeutics with previous experience at Cellarity and Ragon Institute of MGH, MIT and Harvard. At Ragon Institute, Joshua focused on characterizing and altering killer T cells in response to HIV-infected target cells. Joshua also contributed to a manuscript accepted in Nature Immunology. In their current role at Abata Therapeutics, Joshua continues to leverage their expertise in molecular biology and immunology.